Companhia Siderurgica Nacional S.A. Common Stock (SID)

Total Costs & Expenses

R$10.54B

Quarterly · Period ending: · BRL

SID logo

SID Total Costs & Expenses

Latest reportedR$10.54B BRL
SID Quarterly Total Costs & Expenses · BRL (R$512.67M → R$10.54B)
High-resolution chart · PNG

SID total costs & expenses history

Quarterly · BRL. Dates are reporting period ends; fiscal years can differ from calendar years.

Companhia Siderurgica Nacional S.A. Common Stock Total Costs & Expenses — Quarterly (BRL)
Period endingTotal Costs & Expenses (BRL)
10,541,378,000
9,601,500,729
10,603,396,888
9,947,732,000
9,611,625,000
10,019,992,000
10,165,473,000
10,285,108,000
9,268,231,000
9,130,057,000
9,574,938,000
11,990,137,000
9,848,147,000
10,759,678,000
3,487,821,000
9,157,440,999
8,849,050,000
8,108,751,000
-10,178,997,000
6,750,319,000
7,967,172,000
6,800,914,000
4,079,664,000
6,009,780,000
5,079,591,000
4,803,597,000
5,572,615,000
5,592,026,000
5,540,004,000
4,653,355,000
4,739,656,000
4,941,973,000
5,349,881,000
2,428,981,000
3,766,744,000
4,185,478,000
4,016,611,000
3,680,914,000
3,868,899,000
3,633,742,000
4,086,854,000
3,658,226,000
541,974,000
3,545,992,000
3,403,049,000
3,637,173,000
3,645,027,000
3,333,037,000
3,135,729,000
3,504,925,000
2,565,796,000
3,706,422,000
6,802,015,000
2,465,681,000
3,874,085,000
3,632,869,000
3,515,184,000
3,192,174,000
3,717,760,000
2,733,300,000
2,791,908,000
2,599,582,000
4,021,893,000
1,795,427,000
2,386,393,000
2,101,869,000
1,150,077,500
1,527,840,000
2,087,323,000
1,951,045,000
1,840,841,914
4,080,863,644
1,718,134,713
2,122,928,195
1,224,607,431
1,990,423,786
1,693,399,515
1,608,732,426
608,035,935
2,226,736,941
1,271,972,073
1,169,020,780
585,214,305
1,227,479,467
1,272,726,000
1,626,337,961
-402,697,758
1,621,927,992
2,107,051,254
1,400,096,929
1,579,194,602
1,487,045,792
1,218,044,304
1,005,261,094
341,707,655
1,699,010,976
1,368,432,858
1,156,290,394
829,625,000
-86,774,286
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.